NASDAQ: SRPT Investor Notice: Lawsuit Alleges False and Misleading Statements by Sarepta Therapeutics, Inc.
An investor, who purchased shares of Sarepta Therapeutics, Inc. (NASDAQ: SRPT), filed a lawsuit over alleged violations of Federal Securities Laws by Sarepta Therapeutics, Inc.
View full press release